From ideals to execution – exploring the realities of patient-centricity

Author Photo
Ashfield Healthcare Communications
29 Jun 2016

The Ashfield Patients & Pharma Future Forum explores the reality of patient-centricity in 2016 and what’s next for pharma.

As a major provider of services to the pharmaceutical industry, we wanted to better understand the needs of the industry in the patient space, to evolve in partnership with our clients and continue to provide innovative solutions that improve health outcomes.

Since eyeforpharma, Barcelona 2015, we have heard industry, vendors, specialists, advocacy groups and patients talking about patient-centricity: what is it? What does it mean for the industry and the wider healthcare environment? What does it mean for patients? What will it look like in the future?

These questions were posed to a select group of  the industry’s leading pharma companies during the Ashfield Patients & Pharma Future Forum earlier this year. Our “Ideals to execution” whitepaper provides insight from those discussions and what’s next for pharma in its journey to become truly patient-centric.

Download the whitepaper using the link to the right.

Simple Share Buttons